onthepluto.com
Map
← One event, many countries

New Hepatitis B drug approved by US FDA offers patients a chance to ditch lifelong medication

6 headlines · —

4 parts of the world write

writing more than usual silent, though they usually cover it not writing

How it was told

The most unlike headlines from different parts of the world — the outlets’ own words.

Russia FDA approves first antisense oligonucleotide to treat hepatitis B N+1 · 2 headlines from this part of the world Europe FDA approves hepatitis B shot that may let some patients stop all treatment Medical Xpress · 1 headline from this part of the world USA FDA Approves Hibsago to Treat Certain Chronic HBV Patients Medscape · 2 headlines from this part of the world Africa New Hepatitis B drug approved by US FDA offers patients a chance to ditch lifelong medication Graphic Online (Ghana) · 1 headline from this part of the world

How the story spread

each bar — 3 hours
Africa Europe Russia USA

Who wrote first

  1. USA FDA
  2. Russia Farmvestnik
  3. Africa Graphic Online (Ghana)
  4. Europe Medical Xpress

How it is reported

Russia

N+1 original
FDA approves first antisense oligonucleotide to treat hepatitis B
Farmvestnik original
New FDA-approved drug can cure hepatitis B for the first time

USA

Medscape
FDA Approves Hibsago to Treat Certain Chronic HBV Patients
FDA
FDA Approves First-of-Its-Kind Chronic Hepatitis B Treatment

Europe

Medical Xpress
FDA approves hepatitis B shot that may let some patients stop all treatment

Africa

Graphic Online (Ghana)
New Hepatitis B drug approved by US FDA offers patients a chance to ditch lifelong medication

Headlines are grouped into events automatically, by meaning: an event gathers different outlets' news about the same thing. We claim nothing — we only show who wrote what and when. “More” and “less than usual” compare with how much this part of the world usually writes about events many others cover.

Facts and findings of the day — on Telegram One post every morning: the main things from every section